Sentinus LLC’s Tenet Healthcare THC Stock Holding History

Sentinus LLC’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,590	Closed	-$316K	–	658
2025 Q4	$316K	Buy	+1,590	New	+$321K	0.03%	409

Other funds holding THC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sentinus LLC's THC Position: Q1 2026 in Review

Sentinus LLC sold out of Tenet Healthcare (THC) in Q1 2026, closing a stake of 1,590 shares — an estimated $316K sold.

Sentinus LLC first reported a position in THC in Q4 2025 and held it in 1 quarter. The position peaked at $316K in Q4 2025. 695 funds tracked by Wall St. Rank hold THC as of Q1 2026.

Sentinus LLC reported no remaining Tenet Healthcare position as of Q1 2026 after selling out during the quarter.
Sentinus LLC sold 1,590 Tenet Healthcare shares in Q1 2026, an estimated $316K.
Sentinus LLC first reported a position in Tenet Healthcare in Q4 2025 and held it in 1 quarter.
Sentinus LLC's Tenet Healthcare position peaked at $316K in Q4 2025.
695 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.

Based on Sentinus LLC's 13F filing for Q1 2026, filed 6 May 2026.